As mycotoxin challenges intensify due to shifting climate conditions, ANH’s investment positions the company to better support feed manufacturers with advanced risk management solutions.
The report found that co-contamination, the presence of more than one mycotoxin in a single sample, is increasingly the norm rather than the exception.
DSM-Firmenich confirmed in early 2024 that it intends to carve out the ANH division by the end of 2025.
The launch comes at a time when pig producers worldwide are grappling with the challenges of managing early-life stress in piglets, particularly during critical transition periods, such as weaning.
During the 25-year-old partnership, Novonesis was responsible for research, development and production, while dsm-firmenich managed distribution and sales.
The announcement was made as part of dsm-firmenich’s commitment to scaling up Bovaer, a feed additive developed over 15 years to reduce enteric methane emissions in cattle.
At the heart of the partnership is the development of a new sustainability module within the Allix platform, powered by Sustell™.
The partnership’s central objective is to support producers in accurately measuring environmental footprints, calculating emissions, and verifying reductions.
As part of its broader portfolio evolution, the company confirmed the ongoing exit from the Animal Nutrition & Health segment is “advancing as planned.”
It confirms that DSM 11798 remains safe for use in feed for pigs and all avian species under previously approved conditions.